| # | Title | Journal | Year | Citations |
|---|
| 1 | Mechanism linking diabetes mellitus and obesity | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2014 | 619 |
| 2 | <p>How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases</p> | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2019 | 378 |
| 3 | <p>Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship</p> | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2019 | 285 |
| 4 | The economic impact of obesity in the United States | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2010 | 273 |
| 5 | The economic impact of obesity in the United States | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 0 | 261 |
| 6 | Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2013 | 255 |
| 7 | Importance of family/social support and impact on adherence to diabetic therapy | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2013 | 246 |
| 8 | <p>Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications</p> | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2020 | 232 |
| 9 | Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2014 | 228 |
| 10 | AMPK activation: a therapeutic target for type 2 diabetes? | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2014 | 214 |
| 11 | New onset diabetes after transplantation (NODAT): an overview | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2011 | 185 |
| 12 | Long-term weight loss maintenance for obesity: a multidisciplinary approach | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2016 | 177 |
| 13 | <p>Leptin resistance: underlying mechanisms and diagnosis</p> | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2019 | 175 |
| 14 | Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2013 | 174 |
| 15 | Obesity and nonalcoholic fatty liver disease: current perspectives | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2018 | 167 |
| 16 | Diabetes and sexual dysfunction: current perspectives | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2014 | 157 |
| 17 | Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2012 | 149 |
| 18 | A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2021 | 146 |
| 19 | Childhood obesity: prevention is better than cure | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2016 | 141 |
| 20 | Role of sleep quality in the metabolic syndrome | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2016 | 140 |
| 21 | Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2015 | 139 |
| 22 | Microvesicles/exosomes as potential novel biomarkers of metabolic diseases | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2012 | 138 |
| 23 | Novel biomarkers for prediabetes, diabetes, and associated complications | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2017 | 136 |
| 24 | Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2014 | 135 |
| 25 | Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2015 | 135 |
| 26 | Management of adult diabetic ketoacidosis | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2014 | 127 |
| 27 | Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2013 | 126 |
| 28 | <p>Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment</p> | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2019 | 126 |
| 29 | Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2014 | 123 |
| 30 | Sex differences in type 2 diabetes: focus on disease course and outcomes | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2014 | 122 |
| 31 | The impact of brief high-intensity exercise on blood glucose levels | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2013 | 114 |
| 32 | Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2021 | 113 |
| 33 | Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2010 | 108 |
| 34 | Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2015 | 106 |
| 35 | Diabetes in sub-Saharan Africa – from policy to practice to progress: targeting the existing gaps for future care for diabetes | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2017 | 106 |
| 36 | <p>Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence</p> | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2020 | 105 |
| 37 | Interventions to improve long-term weight loss in patients following bariatric surgery: challenges and solutions | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2015 | 103 |
| 38 | Association between obesity and heart rate variability indices: an intuition toward cardiac autonomic alteration – a risk of CVD | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2017 | 102 |
| 39 | The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 0 | 100 |
| 40 | Is obesity in women protective against osteoporosis? | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2011 | 100 |
| 41 | Clinical features and treatment of maturity onset diabetes of the young (MODY) | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2012 | 99 |
| 42 | Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015 | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2016 | 99 |
| 43 | <p>Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus</p> | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2020 | 99 |
| 44 | Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2011 | 98 |
| 45 | Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 0 | 94 |
| 46 | Prevalence of overweight and obesity in adult Nigerians – a systematic review | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2013 | 92 |
| 47 | Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2017 | 90 |
| 48 | Obesity management in Prader–Willi syndrome: current perspectives | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2018 | 90 |
| 49 | Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2017 | 87 |
| 50 | Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2013 | 85 |
